Genprex, Inc. Stock Issued During Period, Shares, Reverse Stock Splits
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Genprex, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2024-12-31 was 0.00 shares.
- Genprex, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2024-09-30 was -63.40K shares.
- Genprex, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2024-06-30 was 0.00 shares.
- Genprex, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2024-03-31 was 64.69K shares.
- Genprex, Inc. stock issued during period, shares, reverse stock splits for fiscal 2024 was 1.29K shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits 3 month | Stock Issued During Period, Shares, Reverse Stock Splits 12 month |
|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 1.29K shares 10-K · filed 2026-03-30 |
| 2024-09-30 | -63.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | |
| 2024-03-31 | 64.69K shares 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |